- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07261332
Early V/S Delayed Induction of Labour in Patients With Prelabour Rupture of Membranes (PROM)
December 2, 2025 updated by: Laiba Qamar
A Comparative Study on Early Versus Delayed Induction of Labour in Patients With Prelabour Rupture of Membranes at Term
To compare the effects of early V/s delayed induction of labour and its outcomes in patients presenting with PROM without labour.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a comparative study where the patient who presented with PROM were assigned 2 groups of intervention .
One had early induction of labour and other had induction of labour after 24 hours of observation.
Both groups were compared for the average time of labour till delivery of the fetus and the frequency of spontaneous vaginal delivery was also calculated for each group.
Study Type
Interventional
Enrollment (Actual)
88
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Hameed Lateef Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- singleton pregnancy with cephalic presentation
- gestational age between 37-41 weeks as calculated by last menstrual period date or early dating ultrasoumd
- Spontaeous PROM as confirmed by history and sterile speculum examination
- modified bishop score <6
- no detectable uterine contractions on admission
- clear liqour and duration of PROM <6 hours at admission
Exclusion Criteria:
- meconium stained liqour
- patients with features of chorioamnionitis (fever , tachycardia, abdominal tendernessor foul smeeling vaginal discharge
- maternal medical diseaseincluding prompt delivery or C section like severe preeeclampsia, renal or cardiac disease
- presence of contraindications to labour such as placenta previa , Vasa previa,previous uterine surgery (e.g myomectomy ) that increases the risk of uterine rupture , previous C section
- history of antepartum hemorrhage
- Moderate to severe IUGR as diagnosed on ultrasound and doppler studies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: early induction of labour for PROM
The patients assigned with this arm when presented with PROM were inducted immidiately for labour and no observation was done for 24 hours for spontaneous induction of labour
|
In this interventional group patients presenting with PROM will be immediately induced by 0.5mg PGE2 gel.
If bishop score will not improve after 6 hours, then application of PGE2 gel will be repeated (maximum 2 doses)
The patients assigned with this intervention will be observed for 24 hours following which induction will be done using 0.5mg PGE2 gel in posterior fornix of vagina.
|
|
Active Comparator: Late induction of Labour in PROM
The patients assigned with this arm were observed for 24 hours for any spontanous induction of labour and then only proceeded with manual induction.
|
In this interventional group patients presenting with PROM will be immediately induced by 0.5mg PGE2 gel.
If bishop score will not improve after 6 hours, then application of PGE2 gel will be repeated (maximum 2 doses)
The patients assigned with this intervention will be observed for 24 hours following which induction will be done using 0.5mg PGE2 gel in posterior fornix of vagina.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of labour
Time Frame: 24 hours
|
the duration of labour was assesed after each method of induction when patients presented with PROM
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of Normal Vaginal Delivery
Time Frame: 24 hours
|
Frequency of having a vaginal delivery was calculated in each interventional group
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2025
Primary Completion (Actual)
October 10, 2025
Study Completion (Actual)
October 10, 2025
Study Registration Dates
First Submitted
November 20, 2025
First Submitted That Met QC Criteria
December 2, 2025
First Posted (Estimated)
December 3, 2025
Study Record Updates
Last Update Posted (Estimated)
December 3, 2025
Last Update Submitted That Met QC Criteria
December 2, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #PLROM225#
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The participants have not given the cosent to share their personal data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induction of Labor
-
Aalto UniversityUniversity of Minnesota; University of Mississippi Medical CenterNot yet recruitingCervical Ripening | Induction of Birth | Balloon Catheter for Labor Induction | Cervical Ripening and Induction of Labor
-
Aalto UniversityHelsinki University Central Hospital; Tampere University Hospital; Jyväskylä...Not yet recruitingInduction of Labor | Cervical Ripening | Cervical Ripening and Induction of LaborFinland
-
Rambam Health Care CampusNot yet recruitingInduction of Labor
-
Duke UniversityCompleted
-
Ochsner Health SystemNorthwell HealthTerminatedInduction of LaborUnited States
-
Brigham and Women's HospitalCompleted
-
Aultman Health FoundationCompletedInduction of LaborUnited States
-
Dina Yahia MansourUnknown
-
HaEmek Medical Center, IsraelCompletedSingle Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable CervixInduction of LaborIsrael
-
Tel-Aviv Sourasky Medical CenterUnknown
Clinical Trials on 0.5mg PGE2 gel
-
Nilratan Sircar Medical CollegeCompletedPremature Rupture of Membranes at TermIndia
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Nilratan Sircar Medical CollegeCompletedPremature Rupture of Membranes at TermIndia
-
Danish Headache CenterCompletedMigraine | HeadacheDenmark
-
Ain Shams UniversityNorth West Armed Forces HospitalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType2 DiabetesKorea, Republic of
-
Wolfson Medical CenterUnknown
-
Chengdu Kanghong Biotech Co., Ltd.UnknownPolypoid Choroidal Vasculopathy (PCV)China
-
Pharmbio Korea Co., Ltd.Completed
-
Seoul St. Mary's HospitalUnknown